Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King ...
Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
Sulodexide is under clinical development by Alfasigma and currently in Phase III for Venous Thromboembolism. According to GlobalData, Phase III drugs for Venous Thromboembolism have a 60% phase ...
His debut on Boxing Day, which sent shockwaves through the game, was a kaleidoscope of audacious batting and high-octane drama that could drag Test cricket out of its late-20th-century stasis into ...
(MENAFN- Mid-East Info) Riyadh:Aster Sanad Hospital, a unit of the leading integrated healthcare provider Aster DM Healthcare, recently concluded its successful Venous Thrombosis & Hemostasis ...
Velopharyngeal insufficiency (VPI) is a speech condition that occurs when the soft palate and throat are unable to create a seal while speaking. This causes nasal speech that can make the speaker ...